Mr. Caldwell successfully defended Medtronic in a patent infringement lawsuit pending in the District of New Jersey. Local companies Wyeth and Cordis accused Medtronic of infringing patents pertaining to the use of the drug rapamycin (now commercially known as sirolimus) to treat restenosis. The district court granted Medtronic’s motion for summary judgment that invalidated the asserted patents.
